Drug Shortage Report for TEVA-SALBUTAMOL HFA
| Report ID | 243894 |
| Drug Identification Number | 02326450 |
| Brand name | TEVA-SALBUTAMOL HFA |
| Common or Proper name | SALBUTAMOL 100MCG HFA INH |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SALBUTAMOL |
| Strength(s) | 100MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | INHALATION INHALATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 200 |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-26 |
| Estimated end date | 2025-03-20 |
| Actual end date | 2025-03-18 |
| Shortage status | Resolved |
| Updated date | 2025-03-19 |
| Company comments | Product in on allocation for duration of shortage. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2025-03-19 | French | Compare |
| v15 | 2025-03-19 | English | Compare |
| v14 | 2025-03-06 | French | Compare |
| v13 | 2025-03-06 | English | Compare |
| v12 | 2025-02-28 | French | Compare |
| v11 | 2025-02-28 | English | Compare |
| v10 | 2025-02-20 | French | Compare |
| v9 | 2025-02-20 | English | Compare |
| v8 | 2025-01-17 | English | Compare |
| v7 | 2025-01-09 | French | Compare |
| v6 | 2025-01-09 | English | Compare |
| v5 | 2024-12-13 | French | Compare |
| v4 | 2024-12-13 | English | Compare |
| v3 | 2024-11-27 | English | Compare |
| v2 | 2024-11-26 | French | Compare |
| v1 | 2024-11-26 | English | Compare |
Showing 1 to 16 of 16